Literature DB >> 11009498

The management of post-herpetic neuralgia.

A L Cunningham, R H Dworkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11009498      PMCID： PMC1118597          DOI： 10.1136/bmj.321.7264.778

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS.

Authors:  R E HOPE-SIMPSON
Journal:  Proc R Soc Med       Date:  1965-01

2.  Risk factors for postherpetic neuralgia.

Authors:  P W Choo; K Galil; J G Donahue; A M Walker; D Spiegelman; R Platt
Journal:  Arch Intern Med       Date:  1997-06-09

3.  Population-based study of herpes zoster and its sequelae.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  Medicine (Baltimore)       Date:  1982-09       Impact factor: 1.889

4.  Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up.

Authors:  S Helgason; G Petursson; S Gudmundsson; J A Sigurdsson
Journal:  BMJ       Date:  2000-09-30

Review 5.  Assessment of pain in herpes zoster: lessons learned from antiviral trials.

Authors:  R H Dworkin; D Carrington; A Cunningham; R G Kost; M J Levin; M W McKendrick; M N Oxman; B Rentier; K E Schmader; G Tappeiner; S W Wassilew; R J Whitley
Journal:  Antiviral Res       Date:  1997-01       Impact factor: 5.970

6.  Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials.

Authors:  M J Wood; R Kay; R H Dworkin; S J Soong; R J Whitley
Journal:  Clin Infect Dis       Date:  1996-02       Impact factor: 9.079

Review 7.  Pain caused by herpes zoster infection.

Authors:  R S Cluff; M C Rowbotham
Journal:  Neurol Clin       Date:  1998-11       Impact factor: 3.806

8.  Pain responses in Nepalese porters.

Authors:  W C Clark; S B Clark
Journal:  Science       Date:  1980-07-18       Impact factor: 47.728

9.  Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.

Authors:  S Tyring; R A Barbarash; J E Nahlik; A Cunningham; J Marley; M Heng; T Jones; T Rea; R Boon; R Saltzman
Journal:  Ann Intern Med       Date:  1995-07-15       Impact factor: 25.391

10.  Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults.

Authors:  K R Beutner; D J Friedman; C Forszpaniak; P L Andersen; M J Wood
Journal:  Antimicrob Agents Chemother       Date:  1995-07       Impact factor: 5.191
View more
  23 in total

1.  Postherpetic neuralgia. Findings differ from earlier results.

Authors:  D Bowsher
Journal:  BMJ       Date:  2001-04-07

Review 2.  Treatment of herpes zoster and postherpetic neuralgia.

Authors:  Robert W Johnson; Robert H Dworkin
Journal:  BMJ       Date:  2003-04-05

3.  Dementia following herpes zoster encephalitis.

Authors:  Katherine J Bangen; Lisa Delano-Wood; Christina E Wierenga; Nikki H Stricker; John R Hesselink; Mark W Bondi
Journal:  Clin Neuropsychol       Date:  2010-05-24       Impact factor: 3.535

Review 4.  Chickenpox, chickenpox vaccination, and shingles.

Authors:  P D Welsby
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

5.  Treatment of Postherpetic Neuralgia Using Narrow Band Ultraviolet B Radiation (UVB).

Authors:  Piotr Brzezinski; Ewelina Cywinska; Anca Chiriac
Journal:  Maedica (Buchar)       Date:  2015-09

6.  Economic evaluation of a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in older adults in Switzerland.

Authors:  Thomas D Szucs; Reto W Kressig; Manto Papageorgiou; Werner Kempf; Jean-Pierre Michel; Anton Fendl; Xavier Bresse
Journal:  Hum Vaccin       Date:  2011-07-01

Review 7.  Tolerability of treatments for postherpetic neuralgia.

Authors:  Mark W Douglas; Robert W Johnson; Anthony L Cunningham
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  A health economic model for evaluating a vaccine for the prevention of herpes zoster and post-herpetic neuralgia in the UK.

Authors:  Lee Moore; Vanessa Remy; Monique Martin; Maud Beillat; Alistair McGuire
Journal:  Cost Eff Resour Alloc       Date:  2010-04-30

9.  Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.

Authors:  Gordon Irving
Journal:  Ther Adv Chronic Dis       Date:  2012-09       Impact factor: 5.091

10.  Concurrent reactivation of varicella zoster virus and herpes simplex virus in an immunocompetent child.

Authors:  Hyun-Ho Park; Mu-Hyoung Lee
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.